A Phase II Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer

Trial Profile

A Phase II Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jan 2017

At a glance

  • Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 06 Jul 2012 Actual patient number 51 added as reported by ClinicalTrials.gov.(Extension trial: NCT01339832)
    • 06 Jul 2012 Actual patient number 51 added as reported by ClinicalTrials.gov.(Extension trial: NCT01339832)
    • 18 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.(Extension trial: NCT01339832)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top